• Je něco špatně v tomto záznamu ?

The role of nitric oxide during embryonic wound healing

P. Abaffy, S. Tomankova, R. Naraine, M. Kubista, R. Sindelka,

. 2019 ; 20 (1) : 815. [pub] 20191106

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20005722

Grantová podpora
RVO: 86652036 Ministerstvo Školství, Mládeže a Tělovýchovy
CZ.1.05/1.1.00/02.0109 European Regional Development Fund
GA17-24441S Grantová Agentura České Republiky

BACKGROUND: The study of the mechanisms controlling wound healing is an attractive area within the field of biology, with it having a potentially significant impact on the health sector given the current medical burden associated with healing in the elderly population. Healing is a complex process and includes many steps that are regulated by coding and noncoding RNAs, proteins and other molecules. Nitric oxide (NO) is one of these small molecule regulators and its function has already been associated with inflammation and angiogenesis during adult healing. RESULTS: Our results showed that NO is also an essential component during embryonic scarless healing and acts via a previously unknown mechanism. NO is mainly produced during the early phase of healing and it is crucial for the expression of genes associated with healing. However, we also observed a late phase of healing, which occurs for several hours after wound closure and takes place under the epidermis and includes tissue remodelling that is dependent on NO. We also found that the NO is associated with multiple cellular metabolic pathways, in particularly the glucose metabolism pathway. This is particular noteworthy as the use of NO donors have already been found to be beneficial for the treatment of chronic healing defects (including those associated with diabetes) and it is possible that its mechanism of action follows those observed during embryonic wound healing. CONCLUSIONS: Our study describes a new role of NO during healing, which may potentially translate to improved therapeutic treatments, especially for individual suffering with problematic healing.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20005722
003      
CZ-PrNML
005      
20200518132038.0
007      
ta
008      
200511s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12864-019-6147-6 $2 doi
035    __
$a (PubMed)31694542
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Abaffy, Pavel $u Institute of Biotechnology of the Czech Academy of Sciences - BIOCEV, Prumyslova 595, 252 50, Vestec, Czech Republic.
245    14
$a The role of nitric oxide during embryonic wound healing / $c P. Abaffy, S. Tomankova, R. Naraine, M. Kubista, R. Sindelka,
520    9_
$a BACKGROUND: The study of the mechanisms controlling wound healing is an attractive area within the field of biology, with it having a potentially significant impact on the health sector given the current medical burden associated with healing in the elderly population. Healing is a complex process and includes many steps that are regulated by coding and noncoding RNAs, proteins and other molecules. Nitric oxide (NO) is one of these small molecule regulators and its function has already been associated with inflammation and angiogenesis during adult healing. RESULTS: Our results showed that NO is also an essential component during embryonic scarless healing and acts via a previously unknown mechanism. NO is mainly produced during the early phase of healing and it is crucial for the expression of genes associated with healing. However, we also observed a late phase of healing, which occurs for several hours after wound closure and takes place under the epidermis and includes tissue remodelling that is dependent on NO. We also found that the NO is associated with multiple cellular metabolic pathways, in particularly the glucose metabolism pathway. This is particular noteworthy as the use of NO donors have already been found to be beneficial for the treatment of chronic healing defects (including those associated with diabetes) and it is possible that its mechanism of action follows those observed during embryonic wound healing. CONCLUSIONS: Our study describes a new role of NO during healing, which may potentially translate to improved therapeutic treatments, especially for individual suffering with problematic healing.
650    _2
$a zvířata $7 D000818
650    _2
$a embryo nesavčí $x cytologie $x metabolismus $x fyziologie $7 D004625
650    _2
$a regulace genové exprese $7 D005786
650    _2
$a glukosa $x metabolismus $7 D005947
650    _2
$a leptin $x metabolismus $7 D020738
650    _2
$a oxid dusnatý $x metabolismus $7 D009569
650    _2
$a signální transdukce $7 D015398
650    12
$a hojení ran $7 D014945
650    _2
$a Xenopus laevis $7 D014982
655    _2
$a časopisecké články $7 D016428
700    1_
$a Tomankova, Silvie $u Institute of Biotechnology of the Czech Academy of Sciences - BIOCEV, Prumyslova 595, 252 50, Vestec, Czech Republic.
700    1_
$a Naraine, Ravindra $u Institute of Biotechnology of the Czech Academy of Sciences - BIOCEV, Prumyslova 595, 252 50, Vestec, Czech Republic.
700    1_
$a Kubista, Mikael $u Institute of Biotechnology of the Czech Academy of Sciences - BIOCEV, Prumyslova 595, 252 50, Vestec, Czech Republic. TATAA Biocenter, Odinsgatan 28, 411 03, Göteborg, Sweden.
700    1_
$a Sindelka, Radek $u Institute of Biotechnology of the Czech Academy of Sciences - BIOCEV, Prumyslova 595, 252 50, Vestec, Czech Republic. sindelka@ibt.cas.cz.
773    0_
$w MED00008181 $t BMC genomics $x 1471-2164 $g Roč. 20, č. 1 (2019), s. 815
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31694542 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200518132038 $b ABA008
999    __
$a ok $b bmc $g 1524580 $s 1095778
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 20 $c 1 $d 815 $e 20191106 $i 1471-2164 $m BMC genomics $n BMC Genomics $x MED00008181
GRA    __
$a RVO: 86652036 $p Ministerstvo Školství, Mládeže a Tělovýchovy
GRA    __
$a CZ.1.05/1.1.00/02.0109 $p European Regional Development Fund
GRA    __
$a GA17-24441S $p Grantová Agentura České Republiky
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...